Exclusive Interview With Innovus Pharma (INNV) CFO Robert Hoffman -- SECFilings.com
Robert Hoffman Brings Years of Public Company Pharma Experience to His New CFO Role With Innovus Pharmaceuticals (INNV)
(firmenpresse) - REDONDO BEACH, CA -- (Marketwired) -- 09/07/16 -- SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an exclusive interview with Innovus Pharmaceuticals'' (OTCQB: INNV) Robert Hoffman, the company''s newly appointed Chief Financial Officer.
In the interview, Mr. Hoffman discusses his new role with Innovus, growth plans, revenues, and what investors should watch for over the coming quarters. He reiterated the company''s near term goals:
Our first goal is to continue our revenue growth and meet the $5M projected revenue for this year 2016.
Projecting to be profitable in 2017 with annual revenues of $15M in that year.
Expand our product offerings, markets where they can be commercialized and continue our organic growth.
Up-list the Company to a national exchange once the share price appreciation makes sense.
To read the full Q&A, please click here:
Founded in 2004, SECFilings.com provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: .
SECFilings.com
Paul Archie
406-862-2242
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.09.2016 - 04:00 Uhr
Sprache: Deutsch
News-ID 1456490
Anzahl Zeichen: 2348
contact information:
Contact person:
Town:
REDONDO BEACH, CA
Phone:
Kategorie:
Health & Nutrition
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 214 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Exclusive Interview With Innovus Pharma (INNV) CFO Robert Hoffman -- SECFilings.com
"
steht unter der journalistisch-redaktionellen Verantwortung von
SECFilings.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
